Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes

被引:141
|
作者
Bouscary, D
DeVos, J
Guesnu, M
Jondeau, K
Viguier, F
Melle, J
Picard, F
Dreyfus, F
FontenayRoupie, M
机构
[1] HOP COCHIN,ICGM,INSERM,U363,F-75679 PARIS 14,FRANCE
[2] HOP HOTEL DIEU,LAB CYTOGENET,F-75181 PARIS,FRANCE
关键词
myelodysplasia; apoptosis; Fas;
D O I
10.1038/sj.leu.2400654
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Apoptosis of hematopoietic progenitor cells is increased in myelodysplastic syndromes (MDS). We have studied Fas (CD95/Apo-1) antigen expression in 27 MDS patients (RARS 4, RA 3, RAEB 13; RAEB-t 3, CMML 4) and three AML secondary to MDS. We found that the Fas antigen was not expressed on normal bone marrow (BM) CD34(+), CD14(+), or glycophorin(+) cells, and only slightly on CD33(+) cells. Patients with MDS had upregulation of Fas expression on total bone marrow nuclear cells (BMMC) (t-test, P = 0.04), CD34(+) (P = 0.013), CD33(+) (P = 0.04), and glycophorin(+) (P = 0.032) BM cells compared to controls. Pas expression did not correlate to the FAB subtype, the Bournemouth score, or to peripheral cytopenias. However, Fas expression intensity on CD34(+) cells negatively correlated to the BM blasts number (Spearman, P = 0.01) suggesting that leukemic blasts cells lose Fas antigen expression with progression of myelodysplasia. Using both proliferation assays in liquid cultures and clonogenic progenitor assays in the presence of an agonist anti-Fas MoAb (CH11), we showed that the Fas protein was functional in some patients. Dose-dependent inhibition of DNA synthesis was observed in three out of seven patients studied. CFU-GM and BFU-E colonies suppression in some patients suggested that Fas can induce apoptosis in myeloid and erythroid BM progenitors of MDS patients, The TUNEL technique on BM smears gave a mean of 12.6% +/- 2.5 of bone marrow apoptotic cells in five controls. Patients with MDS had increased bone marrow apoptosis (mean 39% +/- 5.7, t-test, P = 0.012). Four out of 15 (26%) patients studied with a sensitive radiolabeled DNA ladder technique had typical DNA ladders indicative of advanced stages of apoptosis. Massive BM suicide was observed in patients with RA (2/2) and RAEB (8/11), whereas apoptosis rates were normal or low in patients with RAEB-t (3/3) or secondary AMLs (3/3). Moreover, high rates of apoptosis correlated to low Bournemouth score (Spearman, P = 0.01). No statistical correlation could be found between Fas expression and apoptosis rates. Our results confirm the importance of programmed cell death in MDS, The Fas antigen is clearly upregulated on BM cells, but its role in the pathophysiology of apoptosis in myelodysplasia is still unclear, indicating that many factors positively or negatively interfere with the Fas-mediated pathway of apoptosis in vivo and in vitro.
引用
收藏
页码:839 / 845
页数:7
相关论文
共 50 条
  • [1] Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes
    D Bouscary
    J De Vos
    M Guesnu
    K Jondeau
    F Viguier
    J Melle
    F Picard
    F Dreyfus
    M Fontenay-Roupie
    Leukemia, 1997, 11 : 839 - 845
  • [2] Fas/APO-1 (CD95) expression in myelodysplastic syndromes
    Lepelley, P
    Grardel, N
    Erny, O
    Iaru, T
    Obein, V
    Cosson, A
    Fenaux, P
    LEUKEMIA & LYMPHOMA, 1998, 30 (3-4) : 307 - 312
  • [3] Fas (CD95/Apo-1) expression and apoptosis in myelodysplasia.
    Bouscary, D
    DeVos, J
    FontenayRoupie, M
    Melle, J
    Jondeau, K
    Picard, F
    Dreyfus, F
    Guesnu, M
    BLOOD, 1996, 88 (10) : 2544 - 2544
  • [4] Role of Fas/Apo1 (CD95) expression in patients with myelodysplastic syndromes
    Mikhaylova, I
    Sokolovskaya, A
    Shishkin, Y
    Logacheva, N
    Inshakov, A
    Burova, O
    Zabotina, T
    Shirin, A
    Volkova, M
    Kochno, A
    Savchenko, V
    Tsvetaeva, N
    Baryshnikov, A
    LEUKEMIA, 2001, 15 (03) : 499 - 499
  • [5] Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis
    Peter, ME
    Krammer, PH
    CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (05) : 545 - 551
  • [6] Sensitivity and resistance to apoptosis in the APO-1 (Fas/CD95) system
    Debatin, KM
    ONKOLOGIE, 1996, 19 : 3 - 5
  • [7] Fas antigen/APO-1 (CD95) expression on myeloma cells
    Shima, Y
    Nishimoto, N
    Yoshizaki, K
    Kishimoto, T
    LEUKEMIA & LYMPHOMA, 1996, 23 (5-6) : 521 - +
  • [8] The CD95(APO-1/Fas) DISC and beyond
    M E Peter
    P H Krammer
    Cell Death & Differentiation, 2003, 10 : 26 - 35
  • [9] CD95(apo-1/fas) signalling and diseases
    Krammer, PH
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 : R1 - R1
  • [10] The CD95(APO-1/Fas) DISC and beyond
    Peter, ME
    Krammer, PH
    CELL DEATH AND DIFFERENTIATION, 2003, 10 (01): : 26 - 35